Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Novartis India LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500672NSE Symbol: NOVARTINDP/E(TTM):21.79
ISIN Demat:INE234A01025Div & Yield %:2.76EPS(TTM):41.63
Book Value(Rs):317.91821Market Cap ( Cr.):2239.46Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 390.09366.84413.52486.66453.73532.69
Excise Duty0.000.000.000.000.000.00
Net Sales390.09366.84413.52486.66453.73532.69
Other Income 41.9661.6858.1133.1933.0936.14
Stock Adjustments -3.75-9.86-2.359.12-10.74-1.83
Total Income428.30418.66469.28528.97476.08567.00
EXPENDITURE :      
Raw Materials 199.07189.98199.34187.26135.88180.49
Power & Fuel Cost0.140.180.350.530.531.27
Employee Cost 18.7222.9635.64101.89108.51113.87
Other Manufacturing Expenses 8.185.0012.5831.1533.5136.19
Selling and Administration Expenses 59.7465.5582.78144.40128.11174.87
Miscellaneous Expenses 9.078.0515.4053.089.6612.14
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure294.92291.72346.09518.31416.20518.83
Operating Profit133.38126.94123.1910.6659.8848.17
Interest 0.771.491.754.837.686.39
Gross Profit132.61125.45121.445.8352.2041.78
Depreciation2.192.616.069.6512.1613.14
Profit Before Tax130.42122.84115.38-3.8240.0428.64
Tax29.9637.631.68-0.4422.6215.22
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.440.0210.340.34-3.483.34
Reported Net Profit100.9085.19103.36-3.7220.9010.08
Extraordinary Items 0.081.990.17-44.680.03-0.01
Adjusted Net Profit100.8283.20103.1940.9620.8710.09
Adjst. below Net Profit 0.971.213.118.19-6.09-24.81
P & L Balance brought forward728.84759.72677.94698.16708.04747.46
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 61.73117.2824.6924.6924.6924.69
P & L Balance carried down768.98728.84759.72677.94698.16708.04
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %500.00500.00950.00200.00200.00200.00
Earnings Per Share-Unit Curr40.8834.5241.88-1.518.474.08
Earnings Per Share(Adj)-Unit Curr40.8834.5241.88-1.518.474.08
Book Value-Unit Curr318.06301.79314.29280.27288.16292.03